Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer

Go back to Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer
(NASDAQ: CADL) Delayed: 13.13 +0.78 (6.32%)
Previous Close $12.35    52 Week High
Open $12.52    52 Week Low
Day High $13.26    P/E N/A 
Day Low $12.38    EPS
Volume 1,339,276